Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions.

M Arakawa, H Miwa, T Noda, K Kagawa, K Nishigaki, Y Ito, T Kawada, S Hirakawa
{"title":"Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions.","authors":"M Arakawa,&nbsp;H Miwa,&nbsp;T Noda,&nbsp;K Kagawa,&nbsp;K Nishigaki,&nbsp;Y Ito,&nbsp;T Kawada,&nbsp;S Hirakawa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Disopyramide, an antiarrhythmic drug, is known to impair cardiac function, but acute cardiac effects of conventional oral dose of disopyramide are not well known. To examine the extent of acute cardiac effects of daily oral dose of disopyramide, we gave 150 mg of disopyramide to thirteen patients with normal or impaired cardiac function, and observed cardiac function on an hourly basis for 3 hours after baseline period. The serum level of disopyramide reached a therapeutic level (2.0-5.0 micrograms/ml) mostly 1 hour after administration. Doppler-echocardiographically determined left ventricular ejection fraction, and the ratio of the peak early filling velocity to the peak atrial filling velocity in left ventricular inflow velocity remained unchanged throughout the experimental period. Other hemodynamic variables, such as blood pressure and heart rate remained unchanged. We conclude that daily oral dose of disopyramide appears to have no significant effects on cardiac function after administration. Disopyramide seems to be safe and may not be necessarily withheld from patients who need it, when hemodynamic variables are to be measured.</p>","PeriodicalId":13817,"journal":{"name":"International journal of clinical pharmacology, therapy, and toxicology","volume":"31 5","pages":"253-9"},"PeriodicalIF":0.0000,"publicationDate":"1993-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical pharmacology, therapy, and toxicology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Disopyramide, an antiarrhythmic drug, is known to impair cardiac function, but acute cardiac effects of conventional oral dose of disopyramide are not well known. To examine the extent of acute cardiac effects of daily oral dose of disopyramide, we gave 150 mg of disopyramide to thirteen patients with normal or impaired cardiac function, and observed cardiac function on an hourly basis for 3 hours after baseline period. The serum level of disopyramide reached a therapeutic level (2.0-5.0 micrograms/ml) mostly 1 hour after administration. Doppler-echocardiographically determined left ventricular ejection fraction, and the ratio of the peak early filling velocity to the peak atrial filling velocity in left ventricular inflow velocity remained unchanged throughout the experimental period. Other hemodynamic variables, such as blood pressure and heart rate remained unchanged. We conclude that daily oral dose of disopyramide appears to have no significant effects on cardiac function after administration. Disopyramide seems to be safe and may not be necessarily withheld from patients who need it, when hemodynamic variables are to be measured.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
常规口服剂量双丙酰胺对左心房和心室功能的急性影响。
已知抗心律失常药物双吡脲会损害心功能,但常规口服双吡脲的急性心脏效应尚不清楚。为了研究每日口服双酰胺对急性心脏的影响程度,我们给13例心功能正常或受损的患者服用150 mg双酰胺,并在基线期后3小时内每小时观察一次心功能。在给药后1小时,患者血清双哌替啶水平基本达到治疗水平(2.0 ~ 5.0微克/ml)。多普勒超声心动图测定左室射血分数,实验期间左室流入流速中早期充血速度峰值与心房充血速度峰值之比保持不变。其他血液动力学变量,如血压和心率保持不变。我们的结论是,每日口服双双酰胺剂量似乎对心功能没有显著影响。当需要测量血流动力学变量时,二丙酰胺似乎是安全的,可能不一定不给需要它的患者使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cocaine and the nervous system. Hemodynamic changes induced by cilazapril and atenolol during isometric stress in hypertensive patients. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol. Is there a relationship between cytarabine pharmacokinetics and keratitis?--A case report. The effects of cimetidine, ranitidine and famotidine on the single-dose pharmacokinetics of naproxen and its metabolites in humans.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1